JAZZ - CIK 0001232524
Jazz Pharmaceuticals plc has filed 2,093 documents with the SEC between 2003 and 2026. The most frequent type is insider trade (1,126 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Major company event | 8-K | 2024-11-06 | 2024-11-06 |
| Insider trade | 4 | 2024-11-05 | 2024-11-01 |
| Insider sale notice | 144 | 2024-11-01 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-10-21 | - |
| Major company event | 8-K | 2024-10-16 | 2024-10-10 |
| Insider trade | 4 | 2024-09-11 | 2024-09-06 |
| Major company event | 8-K | 2024-09-06 | 2024-09-03 |
| Insider sale notice | 144 | 2024-09-05 | - |
| Major company event | 8-K | 2024-08-28 | 2024-08-27 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider trade | 4 | 2024-08-06 | 2024-08-02 |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-05 | - |
| Insider sale notice | 144 | 2024-08-02 | - |
| Quarterly report | 10-Q | 2024-08-01 | 2024-06-30 |
| Major company event | 8-K | 2024-07-31 | 2024-07-31 |
| New insider ownership | 3 | 2024-07-30 | 2024-07-25 |
| Major company event | 8-K | 2024-07-26 | 2024-07-25 |
| Proxy materials | DEFA14A | 2024-07-22 | - |
| Major company event | 8-K | 2024-07-22 | 2024-07-19 |
| Annual report to shareholders | ARS | 2024-06-14 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-06-14 | - |
| Proxy statement | DEF 14A | 2024-06-14 | 2024-07-25 |
| Insider trade | 4 | 2024-06-11 | 2024-06-07 |
| Insider sale notice | 144 | 2024-06-07 | - |
| PRE 14A | - | 2024-06-03 | 2024-07-25 |
| Major company event | 8-K | 2024-05-31 | 2024-05-31 |
| Insider trade | 4 | 2024-05-07 | 2024-05-03 |
| Insider sale notice | 144 | 2024-05-03 | - |
| Quarterly report | 10-Q | 2024-05-02 | 2024-03-31 |
| Major company event | 8-K | 2024-05-01 | 2024-05-01 |
| Annual report (amended) | 10-K/A | 2024-04-26 | 2023-12-31 |
| Insider trade | 4 | 2024-04-09 | 2024-04-05 |
| Insider trade | 4 | 2024-03-08 | 2024-03-06 |